Trial Profile
Strong suppression of the renin-angiotensin system has a renal-protective effect in hypertensive patients: High-dose ARB with ACE inhibitor (Hawaii) study
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 09 Mar 2011
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Valsartan (Primary) ; Imidapril
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms HAWAII
- 09 Mar 2011 New trial record